Latest Reports
Global Idiopathic Pulmonary Fibrosis Treatment Market - Strategic Insights and Forecasts (2025-2030)
The Idiopathic pulmonary fibrosis market is evaluated at US$3.459 billion for the year 2022 growing at a CAGR of 11.87% reaching the market size of US$7.585 billion by the year 2029. Idiopathic pulmonary fibrosis is a certain type of sever...
Alpha-1 Antitrypsin Deficiency Treatment Market Size, Share, Opportunities, And Trends By Treatment Type (Augmentation Therapy, Bronchodilator, Corticosteroids, Oxygen Therapy, Others), By Route of Administration (Parenteral, Inhalation, Oral), By End-user (Speciality clinics, Hospitals, Pharmacies, Others), And By Geography - Forecasts From 2024 To 2029
The Alpha-1 antitrypsin deficiency treatment market is anticipated to expand at a high CAGR over the forecast period. The market for treatments for Alpha-1 Antitrypsin Deficiency (AATD) is expanding significantly due to improvements in the...
Gaucher Disease Treatment Market Size, Share, Opportunities, And Trends By Treatment Type (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Surgical Procedure), By Disease Type (Type I, Type II, Type III), By End-Users (Hospitals, Ambulatory Specialty Clinics, Clinical Research Institutes), And By Geography - Forecasts From 2024 To 2029
The Gaucher disease treatment market is projected to grow at a CAGR of 2.24% during the forecast period, reaching US$1,248.479 million by 2029, from US$1,069.222 million in 2022. Gaucher disease is characterized by the build-up of glucocer...
Cartilage Repair Market Size, Share, Opportunities, And Trends By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline, Fibrocartilage), By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Site (Knee Cartilage Repair, Hip Cartilage Repair, Ankle and Foot Cartilage Repair, Others), And By Geography - Forecasts From 2024 To 2029
The cartilage repair market is experiencing significant growth driven by the rising prevalence of joint-related disorders and injuries worldwide. Cartilage repair procedures are essential for addressing conditions such as osteoarthritis, sp...
Neuropathic Pain Market Size, Share, Opportunities, And Trends By Drug Class (Tricyclic Anti-Depressant, Anticonvulsant, Local Anesthesia, Opioids, Steroids, Others), By Indication (Diabetic neuropathy, Chemotherapy-induced Peripheral neuropathy, Others), By Distribution Channel (Retail Pharmacies, Drug Store, Online Pharmacies), And By Geography - Forecasts From 2024 To 2029
The neuropathic pain market is anticipated to expand at a high CAGR over the forecast period. Neuropathic pain, a challenging and often debilitating condition, stems from damage or dysfunction of the nerves, typically outside the brain and...
Atrial Septal Defect Market Size, Share, Opportunities, And Trends By Symptoms (Frequent Respiratory Infections, Swelling Legs and Feet, Heart Palpitations, Fatigue), By Diagnosis (Chest X-ray, Electrocardiogram), By End-User (Hospitals, Clinics, Others), And By Geography - Forecasts From 2024 To 2029
The atrial septal defect market was valued at US$2.431 billion in 2022. One of the most prevalent congenital heart diseases (CHDs) and the most prevalent CHD in adults is atrial septal defect (ASD). Over the past few decades, the therapy a...
Cystic Fibrosis Market Size, Share, Opportunities, And Trends By Drug Class (CFTR Modulators, Mucolytics, Brochodilators, Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital, Retail Pharmacies, Others), And By Geography - Forecasts From 2024 To 2029
The cystic fibrosis market was valued at US$9,291.199 million in 2022. The cells that make mucus, perspiration, and digestive fluids are impacted by cystic fibrosis. The secretions clog up tubes, ducts, and passages rather than lubricating...
Intravenous (IV) Hydration Therapy Market Size, Share, Opportunities, And Trends By Type (IV Push, IV Drip), By medical applications (IV Vitamin Therapy, Immunity IV Infusion, Weight Loss IV Drip, Pregnancy Symptom Alleviation, Others), By End-user (Hospitals, Others), And By Geography - Forecasts From 2023 To 2028
The intravenous (IV) hydration therapy market is projected to show steady growth during the forecast period. IV hydration therapy is a medical procedure designed to administer fluids directly into the bloodstream through a vein, offering a...
Gene Therapy For Neurodegenerative Diseases Market Size, Share, Opportunities, And Trends Type Of Neurogenerative Disease (Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis (Als), Multiple System Atrophy (Msa), Spinocerebellar Ataxias, Others), By Therapeutic Approach (Gene Replacement Therapy, Gene Silencing Therapy (Rnai), Gene Editing Therapy (Crispr-Cas9), Neurotrophic Factor Delivery, Enzyme Replacement Therapy), By Vector Type (Adeno-Associated Virus (Aav), Lentivirus, Retrovirus, Non-Viral Vectors), By End-User (Hospitals And Clinics, Research Institutions, Biotechnology Companies, Pharmaceutical Companies), And By Geography - Forecasts From 2023 To 2028
The gene therapy for neurodegenerative diseases market was valued at US$81.016 million in 2021. The gene therapy for neurodegenerative diseases market is a fast-growing sector in medical innovation, bringing fresh hope for treating disease...
Emergence of COVID - 19: Outlook for Travel, Sports and Healthcare Industries
COVID-19 is the pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organisation Country Office in China on December 31st, 2019. The outbreak was declared as a Public Health Emergency of Internation...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.